Nektar Therapeutics
NKTR
NKTR
142 hedge funds and large institutions have $124M invested in Nektar Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.29% less ownership
Funds ownership: 5.1% → 4.8% (-0.29%)
32% less capital invested
Capital invested by funds: $183M → $124M (-$59.3M)
Holders
142
Holding in Top 10
–
Calls
$218K
Puts
$5K
Top Buyers
| 1 | +$3.44M | |
| 2 | +$3.02M | |
| 3 | +$2.78M | |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$2.04M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.44M |
Top Sellers
| 1 | -$13M | |
| 2 | -$6.1M | |
| 3 | -$2.56M | |
| 4 |
AI
Acuitas Investments
Seattle,
Washington
|
-$1.43M |
| 5 |
SC
Shay Capital
New York
|
-$1.16M |